ClinicalTrials.Veeva

Menu
P

Perpetual Succour Hospital | Cebu Cancer Institute - Oncology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pregabalin
Bevacizumab
Farletuzumab
Pegcetacoplan
Taxane
Tofacitinib
ANX005
Azvudine
Platinum
Adalimumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

This study is intended to evaluate the efficacy and safety of ANX005 administered by intravenous (IV) infusion to participants recently diagnosed wit...

Enrolling
Guillain-Barre Syndrome
Drug: Placebo
Drug: ANX005

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection...

Enrolling
SARS-CoV-2 Infection
Drug: Placebo
Drug: Azvudine

The purpose of this Proof of Concept (PoC) and Dose-finding (DF) basket study is to evaluate the efficacy and safety of orally administered Enpatoran...

Active, not recruiting
Systemic Lupus Erythematosus
Drug: Enpatoran low dose
Drug: Placebo

Trial sponsors

Viatris logo
A
A
Fresenius Kabi logo
Genentech logo
H
Ipsen logo
Merck KGaA (EMD Serono) logo
M
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems